183 related articles for article (PubMed ID: 24838688)
1. hiPSC Modeling of Inherited Cardiomyopathies.
Jung G; Bernstein D
Curr Treat Options Cardiovasc Med; 2014 Jul; 16(7):320. PubMed ID: 24838688
[TBL] [Abstract][Full Text] [Related]
2. Modeling incomplete penetrance in arrhythmogenic cardiomyopathy by human induced pluripotent stem cell derived cardiomyocytes.
De Bortoli M; Meraviglia V; Mackova K; Frommelt LS; König E; Rainer J; Volani C; Benzoni P; Schlittler M; Cattelan G; Motta BM; Volpato C; Rauhe W; Barbuti A; Zacchigna S; Pramstaller PP; Rossini A
Comput Struct Biotechnol J; 2023; 21():1759-1773. PubMed ID: 36915380
[TBL] [Abstract][Full Text] [Related]
3. Engineered heart tissue models from hiPSC-derived cardiomyocytes and cardiac ECM for disease modeling and drug testing applications.
Goldfracht I; Efraim Y; Shinnawi R; Kovalev E; Huber I; Gepstein A; Arbel G; Shaheen N; Tiburcy M; Zimmermann WH; Machluf M; Gepstein L
Acta Biomater; 2019 Jul; 92():145-159. PubMed ID: 31075518
[TBL] [Abstract][Full Text] [Related]
4. Drug screening using a library of human induced pluripotent stem cell-derived cardiomyocytes reveals disease-specific patterns of cardiotoxicity.
Liang P; Lan F; Lee AS; Gong T; Sanchez-Freire V; Wang Y; Diecke S; Sallam K; Knowles JW; Wang PJ; Nguyen PK; Bers DM; Robbins RC; Wu JC
Circulation; 2013 Apr; 127(16):1677-91. PubMed ID: 23519760
[TBL] [Abstract][Full Text] [Related]
5. Modeling of arrhythmogenic right ventricular cardiomyopathy with human induced pluripotent stem cells.
Caspi O; Huber I; Gepstein A; Arbel G; Maizels L; Boulos M; Gepstein L
Circ Cardiovasc Genet; 2013 Dec; 6(6):557-68. PubMed ID: 24200905
[TBL] [Abstract][Full Text] [Related]
6. Cardiomyopathy in a dish: using human inducible pluripotent stem cells to model inherited cardiomyopathies.
Kamdar F; Klaassen Kamdar A; Koyano-Nakagawa N; Garry MG; Garry DJ
J Card Fail; 2015 Sep; 21(9):761-70. PubMed ID: 25934595
[TBL] [Abstract][Full Text] [Related]
7. Divergent effects of adrenaline in human induced pluripotent stem cell-derived cardiomyocytes obtained from hypertrophic cardiomyopathy.
Prajapati C; Ojala M; Aalto-Setälä K
Dis Model Mech; 2018 Feb; 11(2):. PubMed ID: 29361520
[TBL] [Abstract][Full Text] [Related]
8. Modeling Cardiomyopathies in a Dish: State-of-the-Art and Novel Perspectives on hiPSC-Derived Cardiomyocytes Maturation.
Lodola F; De Giusti VC; Maniezzi C; Martone D; Stadiotti I; Sommariva E; Maione AS
Biology (Basel); 2021 Jul; 10(8):. PubMed ID: 34439963
[TBL] [Abstract][Full Text] [Related]
9. Structural Immaturity of Human iPSC-Derived Cardiomyocytes:
Koivumäki JT; Naumenko N; Tuomainen T; Takalo J; Oksanen M; Puttonen KA; Lehtonen Š; Kuusisto J; Laakso M; Koistinaho J; Tavi P
Front Physiol; 2018; 9():80. PubMed ID: 29467678
[No Abstract] [Full Text] [Related]
10. iPCS Cell Modeling of Inherited Cardiac Arrhythmias.
Shinnawi R; Gepstein L
Curr Treat Options Cardiovasc Med; 2014 Sep; 16(9):331. PubMed ID: 25080030
[TBL] [Abstract][Full Text] [Related]
11. Large-Scale Simulation of the Phenotypical Variability Induced by Loss-of-Function Long QT Mutations in Human Induced Pluripotent Stem Cell Cardiomyocytes.
Paci M; Casini S; Bellin M; Hyttinen J; Severi S
Int J Mol Sci; 2018 Nov; 19(11):. PubMed ID: 30428582
[TBL] [Abstract][Full Text] [Related]
12. Switch From Fetal to Adult
Veerman CC; Mengarelli I; Lodder EM; Kosmidis G; Bellin M; Zhang M; Dittmann S; Guan K; Wilde AAM; Schulze-Bahr E; Greber B; Bezzina CR; Verkerk AO
J Am Heart Assoc; 2017 Jul; 6(7):. PubMed ID: 28739862
[TBL] [Abstract][Full Text] [Related]
13. The Emergence of Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes (hiPSC-CMs) as a Platform to Model Arrhythmogenic Diseases.
Pourrier M; Fedida D
Int J Mol Sci; 2020 Jan; 21(2):. PubMed ID: 31963859
[TBL] [Abstract][Full Text] [Related]
14. Cryopreservation of human pluripotent stem cell-derived cardiomyocytes is not detrimental to their molecular and functional properties.
van den Brink L; Brandão KO; Yiangou L; Mol MPH; Grandela C; Mummery CL; Verkerk AO; Davis RP
Stem Cell Res; 2020 Mar; 43():101698. PubMed ID: 31945612
[TBL] [Abstract][Full Text] [Related]
15. Complex aberrant splicing in the induced pluripotent stem cell-derived cardiomyocytes from a patient with long QT syndrome carrying KCNQ1-A344Aspl mutation.
Wuriyanghai Y; Makiyama T; Sasaki K; Kamakura T; Yamamoto Y; Hayano M; Harita T; Nishiuchi S; Chen J; Kohjitani H; Hirose S; Yokoi F; Gao J; Chonabayashi K; Watanabe K; Ohno S; Yoshida Y; Kimura T; Horie M
Heart Rhythm; 2018 Oct; 15(10):1566-1574. PubMed ID: 29857160
[TBL] [Abstract][Full Text] [Related]
16. Modeling of
Shah D; Virtanen L; Prajapati C; Kiamehr M; Gullmets J; West G; Kreutzer J; Pekkanen-Mattila M; Heliö T; Kallio P; Taimen P; Aalto-Setälä K
Cells; 2019 Jun; 8(6):. PubMed ID: 31208058
[TBL] [Abstract][Full Text] [Related]
17. Pharmacological Protein Kinase C Modulators Reveal a Pro-hypertrophic Role for Novel Protein Kinase C Isoforms in Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes.
Pohjolainen L; Easton J; Solanki R; Ruskoaho H; Talman V
Front Pharmacol; 2020; 11():553852. PubMed ID: 33584253
[No Abstract] [Full Text] [Related]
18. Studying arrhythmogenic right ventricular dysplasia with patient-specific iPSCs.
Kim C; Wong J; Wen J; Wang S; Wang C; Spiering S; Kan NG; Forcales S; Puri PL; Leone TC; Marine JE; Calkins H; Kelly DP; Judge DP; Chen HS
Nature; 2013 Feb; 494(7435):105-10. PubMed ID: 23354045
[TBL] [Abstract][Full Text] [Related]
19. Maturation-Based Model of Arrhythmogenic Right Ventricular Dysplasia Using Patient-Specific Induced Pluripotent Stem Cells.
Wen JY; Wei CY; Shah K; Wong J; Wang C; Chen HS
Circ J; 2015; 79(7):1402-8. PubMed ID: 25971409
[TBL] [Abstract][Full Text] [Related]
20. Patch-Clamp Recording from Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes: Improving Action Potential Characteristics through Dynamic Clamp.
Verkerk AO; Veerman CC; Zegers JG; Mengarelli I; Bezzina CR; Wilders R
Int J Mol Sci; 2017 Aug; 18(9):. PubMed ID: 28867785
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]